Search
chronic migraine headache
see migraine headache
Clinical trial:
- atogepant 30 mg twice a day & 60 mg once a day reduce mean monthly migraine days
- baseline: 19 monthly migraine days
- with atogepant: 12 monthly migraine days
- with placebo: 14 monthly migraine days [1]
General
migraine headache
chronic pain
References
- Pozo-Rosich P, Ailani J, Ashina M, et al.
Atogepant for the preventive treatment of chronic migraine (PROGRESS):
a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet. 2023 Jul 26:S0140-6736(23)01049-8
PMID: 37516125
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01049-8/fulltext